GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Accustem Sciences Inc (OTCPK:ACUT) » Definitions » YoY EBITDA Growth

Accustem Sciences (Accustem Sciences) YoY EBITDA Growth : 36.99% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Accustem Sciences YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Accustem Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 36.99%.

Accustem Sciences's EBITDA per Share for the three months ended in Mar. 2024 was $-0.05.


Accustem Sciences YoY EBITDA Growth Historical Data

The historical data trend for Accustem Sciences's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accustem Sciences YoY EBITDA Growth Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23
YoY EBITDA Growth
- 47.06

Accustem Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only 7.59 65.26 32.91 74.42 36.99

Accustem Sciences YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Accustem Sciences's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.18--0.34)/ | -0.34 |
=47.06 %

Accustem Sciences's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.046--0.073)/ | -0.073 |
=36.99 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accustem Sciences YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Accustem Sciences's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Accustem Sciences (Accustem Sciences) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
5 Penn Plaza, Suite 1954, Floor 19, New York, NY, USA, 10001
Accustem Sciences Inc is a life sciences company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology to empower patients and care team with critical answers and tools and drive innovation in healthcare.